Retevmo is a prescription medicine that is used to treat certain cancers caused by abnormal RET genes in:
adults with non-small cell lung cancer (NSCLC) that has spread.
adults and children 12 years of age and older with advanced medullary thyroid cancer (MTC) or MTC that has spread who require a medicine by mouth or injection (systemic therapy).
adults and children 12 years of age and older with advanced thyroid cancer or thyroid cancer that has spread who require a medicine by mouth or injection (systemic therapy) and who have received radioactive iodine and it did not work or is no longer working.
Your healthcare provider will perform a test to make sure that Retevmo is right for you.
It is not known if this medicine is safe and effective in children younger than 12 years of age.
